These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21274621)

  • 41. Tolerance in DLA-haploidentical canine littermates following CD6-depleted marrow transplantation and donor lymphocyte transfusion.
    Zorn J; Herber M; Schwamberger S; Panzer W; Adler H; Kolb HJ
    Exp Hematol; 2009 Aug; 37(8):998-1006. PubMed ID: 19446000
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
    Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H
    Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Augmentation of antitumor immune responses after adoptive transfer of bone marrow derived from donors immunized with tumor lysate-pulsed dendritic cells.
    Asavaroengchai W; Kotera Y; Koike N; Pilon-Thomas S; Mulé JJ
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):524-33. PubMed ID: 15282530
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo anticancer synergy mechanism of doxorubicin and verapamil combination treatment is impaired in BALB/c mice with metastatic breast cancer.
    McCarthy M; Auda G; Agrawal S; Taylor A; Backstrom Z; Mondal D; Moroz K; Dash S
    Exp Mol Pathol; 2014 Aug; 97(1):6-15. PubMed ID: 24780744
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Alloreactive NK cells enhance the effect of donor lymphocyte infusion in the management of relapsed lung cancer after haploidentical hematopoietic stem cell transplantation].
    Yu JP; Sun HY; Li H; Cao S; Xin N; Ren XB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):164-9. PubMed ID: 19236771
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effect of alloreactive natural killer cells on immune reconstitution in mouse haploidentical bone marrow transplantation].
    Wang H; Wang H; Liu YH; Feng SZ; Han MZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1171-5. PubMed ID: 23114142
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The preventive oral supplementation of a selenium nanoparticle-enriched probiotic increases the immune response and lifespan of 4T1 breast cancer bearing mice.
    Yazdi MH; Mahdavi M; Kheradmand E; Shahverdi AR
    Arzneimittelforschung; 2012 Nov; 62(11):525-31. PubMed ID: 22945771
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Loss of Host Type-I IFN Signaling Accelerates Metastasis and Impairs NK-cell Antitumor Function in Multiple Models of Breast Cancer.
    Rautela J; Baschuk N; Slaney CY; Jayatilleke KM; Xiao K; Bidwell BN; Lucas EC; Hawkins ED; Lock P; Wong CS; Chen W; Anderson RL; Hertzog PJ; Andrews DM; Möller A; Parker BS
    Cancer Immunol Res; 2015 Nov; 3(11):1207-17. PubMed ID: 26198985
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of resveratrol on growth of 4T1 breast cancer cells in vitro and in vivo.
    Bove K; Lincoln DW; Tsan MF
    Biochem Biophys Res Commun; 2002 Mar; 291(4):1001-5. PubMed ID: 11866465
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antitumor enhancement by irradiated haploidentical donor lymphocyte infusion of mice with melanoma.
    Zhu Y; Lai X; Zhao S; Zheng J; Wang X; Weng X; Li J; Ye Y; Chen Q; Lin X
    Cell Physiol Biochem; 2015; 35(6):2181-91. PubMed ID: 25896499
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased expression of P-glycoprotein is associated with doxorubicin chemoresistance in the metastatic 4T1 breast cancer model.
    Bao L; Haque A; Jackson K; Hazari S; Moroz K; Jetly R; Dash S
    Am J Pathol; 2011 Feb; 178(2):838-52. PubMed ID: 21281816
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hemolytic anemia due to passenger lymphocyte syndrome in solid malignancy patients treated with allogeneic natural killer cell products.
    Skeate R; Singh C; Cooley S; Geller M; Northouse J; Welbig J; Slungaard A; Miller J; McKenna D
    Transfusion; 2013 Feb; 53(2):419-23. PubMed ID: 23113867
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer.
    Geller MA; Cooley S; Judson PL; Ghebre R; Carson LF; Argenta PA; Jonson AL; Panoskaltsis-Mortari A; Curtsinger J; McKenna D; Dusenbery K; Bliss R; Downs LS; Miller JS
    Cytotherapy; 2011 Jan; 13(1):98-107. PubMed ID: 20849361
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Murine breast carcinoma 4T1 cells are more sensitive to atranorin than normal epithelial NMuMG cells in vitro: Anticancer and hepatoprotective effects of atranorin in vivo.
    Solár P; Hrčková G; Koptašíková L; Velebný S; Solárová Z; Bačkor M
    Chem Biol Interact; 2016 Apr; 250():27-37. PubMed ID: 26969521
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Allogeneic NK cells as potent antileukemic effector cells after allogeneic bone marrow transplantation in mice.
    Zeis M; Uharek L; Glass B; Gaska T; Steinmann J; Gassmann W; Löffler H; Müller-Ruchholtz W
    Transplantation; 1995 Jun; 59(12):1734-6. PubMed ID: 7604444
    [No Abstract]   [Full Text] [Related]  

  • 56. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer.
    Miller JS; Soignier Y; Panoskaltsis-Mortari A; McNearney SA; Yun GH; Fautsch SK; McKenna D; Le C; Defor TE; Burns LJ; Orchard PJ; Blazar BR; Wagner JE; Slungaard A; Weisdorf DJ; Okazaki IJ; McGlave PB
    Blood; 2005 Apr; 105(8):3051-7. PubMed ID: 15632206
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Near-infrared imaging of adoptive immune cell therapy in breast cancer model using cell membrane labeling.
    Youniss FM; Sundaresan G; Graham LJ; Wang L; Berry CR; Dewkar GK; Jose P; Bear HD; Zweit J
    PLoS One; 2014; 9(10):e109162. PubMed ID: 25334026
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recipient T Cell Exhaustion and Successful Adoptive Transfer of Haploidentical Natural Killer Cells.
    Williams RL; Cooley S; Bachanova V; Blazar BR; Weisdorf DJ; Miller JS; Verneris MR
    Biol Blood Marrow Transplant; 2018 Mar; 24(3):618-622. PubMed ID: 29197679
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Kinetics and organ distribution of allogeneic natural killer lymphocytes transfused into patients suffering from renal cell carcinoma.
    Brand JM; Meller B; Von Hof K; Luhm J; Bähre M; Kirchner H; Frohn C
    Stem Cells Dev; 2004 Jun; 13(3):307-14. PubMed ID: 15186726
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mouse 4T1 breast tumor model.
    Pulaski BA; Ostrand-Rosenberg S
    Curr Protoc Immunol; 2001 May; Chapter 20():Unit 20.2. PubMed ID: 18432775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.